Transplantation & Immunosuppression
Immunosuppression (IS) is administered to kidney transplant recipients to prevent rejection episodes and loss of the renal allograft. Most centers rely on a triple IS after induction with either interleukin‑2 receptor antibodies or antithymocyte globulin. The most frequently used substances for maintenance IS are glucocorticoids, antimetabolites, mTOR inhibitors (mTORi), calcineurin inhibitors (CNI) and the costimulation blocker belatacept. Guidelines recommend a triple combination consisting of CNIs, antimetabolites and corticosteroids for the majority of patients. The long-term risk for malignancy in general is increased in solid organ recipients compared to the general population. Modification of IS may result in reduced risk for non-melanoma skin cancers but results in higher graft rejection rates and in the case of mTORi, deaths. In the case of posttransplantation lymphoproliferative disorders (PTLD) treatment options are reduction of IS, rituximab, chemotherapy, radiation therapy or a combination of these. The optimal protocol has not yet been established and depends on patient age and status, tumor load, laboratory findings, organ functions (heart, kidney, liver) and PTLD subtype. Posttransplantation diabetes mellitus is a frequent complication after kidney transplantation. Tacrolimus more than cyclosporine A.
Related Conference of Transplantation & Immunosuppression
6th International Conference on Clinical Immunology, Neuropharmacology and Drug Development
22nd International Conference on Nephrology, Urology and Therapeutics
13th European Congress on Nephrology, Internal Medicine and Kidney Diseases
Transplantation & Immunosuppression Conference Speakers
Recommended Sessions
- Acute Kidney Injury (AKI
- Chronic Kidney Disease (CKD) Management
- Diabetic Nephropathy
- Dysproteinemias
- Hypertension and Renal Disorders
- Nephrolithiasis and Urological Disorders
- Nutrition and Metabolism in Nephrology
- Pediatric Nephrology
- Renal Complications of Systemic Diseases
- Renal Genetics and Inherited Kidney Disorders
- Renal Imaging and Diagnostic Techniques
- Renal Pathology
- Renal Physiology and Mechanisms of Kidney Function
- Research and Innovations in Nephrology
- Transplantation & Immunosuppression
Related Journals
Are you interested in
- Acute Kidney Injury - Kidney Care 2024 (UK)
- Advanced Imaging Techniques: 3D Mapping and Functional Assessments - EURO NEPHROLOGY 2024 (Germany)
- AI in Renal Diagnostics: Enhancing Accuracy and Efficiency - EURO NEPHROLOGY 2024 (Germany)
- Biomarkers in Kidney Disease - KIDNEY MEET 2024 (Spain)
- Blockchain in Nephrology: Ensuring Security and Transparency in Health Records - EURO NEPHROLOGY 2024 (Germany)
- Cardiovascular Impact of Kidney Disease - KIDNEY MEET 2024 (Spain)
- Cardiovascular Impacts of Kidney Diseases - Nephrologists 2024 (France)
- Chronic Kidney Disease - KIDNEY MEET 2024 (Spain)
- Clinical Nephrology - Kidney Care 2024 (UK)
- Clinical Nephrology - Nephrologists 2024 (France)
- CRISPR and Gene Editing in Nephrology: Precision Medicine Approaches - EURO NEPHROLOGY 2024 (Germany)
- Critical Care Nephrology - KIDNEY MEET 2024 (Spain)
- Diabetic Nephropathy - Kidney Care 2024 (UK)
- Diabetic Nephropathy - KIDNEY MEET 2024 (Spain)
- Dialysis - Nephrologists 2024 (France)
- Dialysis - Kidney Care 2024 (UK)
- Dialysis - KIDNEY MEET 2024 (Spain)
- Digital Biomarkers in Nephrology: From Wearables to Remote Monitoring - EURO NEPHROLOGY 2024 (Germany)
- Drug Discovery and Preclinical Models - Neuropharmacology 2024 (Scotland)
- Drugs for Kidney Disease - KIDNEY MEET 2024 (Spain)
- Drugs for Kidney Diseases - Kidney Care 2024 (UK)
- Extracellular Vesicles in Renal Communication: Implications for Therapeutics - EURO NEPHROLOGY 2024 (Germany)
- Geriatric Nephrology - Kidney Care 2024 (UK)
- Glomerular Diseases - Nephrologists 2024 (France)
- Hereditary Kidney Disorders - Nephrologists 2024 (France)
- Hypertension & Diabetic Associated Kidney Diseases - Nephrologists 2024 (France)
- Hypertension effect on kidney - KIDNEY MEET 2024 (Spain)
- Immunotherapy for Glomerular Diseases: Targeting the Immune System - EURO NEPHROLOGY 2024 (Germany)
- Kidney and Bladder Cancer - Kidney Care 2024 (UK)
- Kidney and Bladder Stones - Nephrologists 2024 (France)
- Kidney Diseases - Nephrologists 2024 (France)
- Kidney Failure - KIDNEY MEET 2024 (Spain)
- Kidney Stones - KIDNEY MEET 2024 (Spain)
- Kidney Transplantation - Kidney Care 2024 (UK)
- Kidney Transplantation - KIDNEY MEET 2024 (Spain)
- Kidney Transplantation - Nephrologists 2024 (France)
- Kidney Urology - Nephrologists 2024 (France)
- Kidney-on-a-Chip Technology: Mimicking Physiological Conditions for Research - EURO NEPHROLOGY 2024 (Germany)
- Metabolomics in Nephrology: Unraveling Metabolic Pathways in Disease - EURO NEPHROLOGY 2024 (Germany)
- Mineral and Bone Disorder in CKD - KIDNEY MEET 2024 (Spain)
- Nanotechnology in Kidney Therapeutics: Small Solutions, Big Impact - EURO NEPHROLOGY 2024 (Germany)
- Nephrological Treatment - Nephrologists 2024 (France)
- Nephrology - Kidney Care 2024 (UK)
- Nephrology - Nephrologists 2024 (France)
- Nephrology Nursing - Kidney Care 2024 (UK)
- Nephrology Nursing - KIDNEY MEET 2024 (Spain)
- Nephrology Nursing & Health Care - Nephrologists 2024 (France)
- Neuroimmunology and Immunopharmacology - Neuropharmacology 2024 (Scotland)
- Neuroinflammation and Neurodegeneration - Neuropharmacology 2024 (Scotland)
- Neurological Disorders and Therapeutic Innovations - Neuropharmacology 2024 (Scotland)
- Neuropharmacology and Aging - Neuropharmacology 2024 (Scotland)
- Neuropharmacology of Pain Management - Neuropharmacology 2024 (Scotland)
- Neuroplasticity and Cognitive Enhancement - Neuropharmacology 2024 (Scotland)
- Neuropsychopharmacology and Addiction Medicine - Neuropharmacology 2024 (Scotland)
- Neurotransmitter Systems and Drug Development - Neuropharmacology 2024 (Scotland)
- New Updates in Nephrology and Hypertension - Nephrologists 2024 (France)
- Patient-Reported Outcomes and Shared Decision-Making in Nephrology Care - EURO NEPHROLOGY 2024 (Germany)
- Pediatric Nephrology - Kidney Care 2024 (UK)
- Pediatric Nephrology - Nephrologists 2024 (France)
- Pediatric Urology - Nephrologists 2024 (France)
- Pediatrics and Geriatric Nephrology - KIDNEY MEET 2024 (Spain)
- Personalized Nutrition in Nephrology: Tailoring Diets for Renal Health - EURO NEPHROLOGY 2024 (Germany)
- Pharmacogenomics in Renal Drug Response: Customizing Treatments for Individuals - EURO NEPHROLOGY 2024 (Germany)
- Psychiatric Disorders and Pharmacotherapy - Neuropharmacology 2024 (Scotland)
- Renal Health in Aging Populations: Geriatric Nephrology Updates - EURO NEPHROLOGY 2024 (Germany)
- Renal Nutrition - KIDNEY MEET 2024 (Spain)
- Renal Nutrition - Nephrologists 2024 (France)
- Renal Nutrition and Metabolism - Kidney Care 2024 (UK)
- Renal Organoids: Modeling Kidney Diseases for Drug Discovery - EURO NEPHROLOGY 2024 (Germany)
- Renal Pathology & Immunology - Kidney Care 2024 (UK)
- Renal Pathology and Immunology - KIDNEY MEET 2024 (Spain)
- Renal Pathology-Immunology - Nephrologists 2024 (France)
- Renal Regenerative Medicine: Stem Cells and Tissue Engineering - EURO NEPHROLOGY 2024 (Germany)
- Robotic kidney transplantation - KIDNEY MEET 2024 (Spain)
- Smart Dialysis Devices: Innovations for Home-based Renal Therapies - EURO NEPHROLOGY 2024 (Germany)
- Stem Cells in Renal Disorders - KIDNEY MEET 2024 (Spain)
- Surgery for Renal Disease - KIDNEY MEET 2024 (Spain)
- The End Stage Renal Diseases & Chronic Kidney Diseases - Kidney Care 2024 (UK)
- Tubular and Interstitial Diseases - Nephrologists 2024 (France)
- Urinary Tract Infections - Nephrologists 2024 (France)
- Urologic Diseases - Nephrologists 2024 (France)
- Urology - Nephrologists 2024 (France)
- Urology - KIDNEY MEET 2024 (Spain)
- Urology / Urinary Tract Infections - Kidney Care 2024 (UK)
- Women Health and Pregnancy - KIDNEY MEET 2024 (Spain)